Lourdes Mendez, MD, PhD

Dr. Lourdes Mendez received her medical degree from Albert Einstein College of Medicine, as well as a PhD in Cell Biology. She completed her residency at Weill Cornell-New York Presbyterian and while a fellow in hematology/oncology at BIDMC, undertook a post-doctoral fellowship in cancer genetics. Most recently, Dr. Mendez was an Instructor of Medicine at Harvard Medical School and the Leukemia Program Leader at BIDMC. Dr. Mendez is dedicated to both the clinical care of patients with myeloid disorders, and translational research to identify novel therapeutics in high-risk myeloid neoplasms and improve clinical outcomes for patients. As part of a new precision medicine clinic, she sees patients with precursor conditions (CHIP/CCUS) with the goal of early identification of individuals at high risk for developing myeloid neoplasms.